{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-037600","form_type":"8-K","ticker":"AIXC","cik":"0001460702","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.120605+00:00","generated_at":"2026-05-31T02:46:33.454566+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Qualigen Therapeutics receives Nasdaq extension to continue listing through November 19, 2024","bullets":["Received Nasdaq Hearings Panel notice on Sept 11, 2024 granting extension for continued listing.","Must evidence compliance with all applicable Nasdaq criteria by November 19, 2024.","Company is diligently working to fulfill requirements for continued listing on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-037600","json":"https://secwatch.observer/filing/0001493152-24-037600.json","markdown":"https://secwatch.observer/filing/0001493152-24-037600.md","text":"https://secwatch.observer/filing/0001493152-24-037600.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224037600/0001493152-24-037600-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224037600/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:46:33.454566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}